ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,099.96
1.02%
Dow Jones
38,239.66
0.40%
US Dollar vs MXN
17.1601
0.00%
Brent Oil
88.165
0.00%
Bitcoin
63,903.10
0.78%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Nemaura Medical Inc (NMRD)

  7. Nemaura Medical Inc (NMRD) Noticias

NMRD Nemaura Medical Inc

0.1053
0.00 (0.00%)
25 Abr 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Nemaura Medical Inc NMRD NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.00 0.00% 0.1053 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
0.1053 0.1053
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
19/4/202415:05EDGAR2Form PRE 14C - Other preliminary information statements
10/4/202415:16EDGAR2Form 8-K - Current report
26/2/202415:05EDGAR2Form 8-K - Current report
22/1/202415:15GLOBEMaxim Group LLC to Host the 2024 Healthcare IT Virtual..
17/1/202416:17EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
17/1/202416:15EDGAR2Form DEF 14A - Other definitive proxy statements
09/1/202416:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202416:29EDGAR2Form 3 - Initial statement of beneficial ownership of..
03/1/202415:30EDGAR2Form 8-K - Current report
03/1/202406:00EDGAR2Form 8-K - Current report
03/1/202406:00GLOBEImportant Update on Listing Status and Strategic Direction
13/12/202307:00EDGAR2Form 8-K - Current report
13/12/202307:00GLOBENemaura Medical Inc. Receives Positive Nasdaq Listing..
07/12/202309:46EDGAR2Form PRE 14A - Other preliminary proxy statements
21/11/202307:38EDGAR2Form 8-K - Current report
21/11/202307:30GLOBENemaura Medical Inc. Secures $10 Million Non-Dilutive Credit..
14/11/202307:00GLOBENemaura Launches Direct to Consumer Offering of Metabolic..
13/11/202315:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202315:15EDGAR2Form 8-K - Current report
13/11/202315:14GLOBENemaura Medical Reports Fiscal Second Quarter 2024 Results..
12/10/202315:05EDGAR2Form 8-K - Current report
06/10/202315:10EDGAR2Form 8-K - Current report
26/9/202308:50GLOBENemaura Medical Announces Appointment of Mr Nikolai Rozanov..
22/9/202314:05GLOBEMaxim Group LLC to Host the Virtual Tech Conference Series:..
18/9/202308:15GLOBENemaura Medical to Present at the Maxim Group Emerging..
14/9/202307:00EDGAR2Form 8-K - Current report
14/9/202307:00GLOBENemaura Medical Provides Update on Nasdaq Compliance Status..
13/9/202307:03EDGAR2Form 8-K - Current report
13/9/202307:00GLOBENemaura Medical Announces Interim Results from its..
12/9/202308:26GLOBENemaura Medical Announces Participation at HLTH 2023, Las..
11/9/202315:41EDGAR2Form 424B8 - Prospectus filed pursuant to Rule 424(b)(8)
11/9/202308:00EDGAR2Form 8-K - Current report
08/9/202315:30EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
08/9/202315:15EDGAR2Form DEF 14A - Other definitive proxy statements
17/8/202307:30EDGAR2Form 8-K - Current report
17/8/202307:30GLOBENemaura Medical Announces SFDA Approval of sugarBEAT®
14/8/202307:35EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202307:30EDGAR2Form 8-K - Current report
14/8/202307:30GLOBENemaura Medical Reports Fiscal First Quarter 2024 Results..
11/8/202316:07EDGAR2Form 8-K - Current report
11/8/202315:05GLOBENemaura Medical Secures $6.5m in Non-Dilutive Funding
10/8/202315:05EDGAR2Form PRE 14A - Other preliminary proxy statements
03/8/202315:08EDGAR2Form POS AM - Post-Effective amendments for registration..
17/7/202308:30EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
14/7/202308:25GLOBENemaura Medical Reports Financial Results and Provides..
14/7/202308:18EDGAR2Form 8-K - Current report
13/7/202315:31EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
29/6/202305:05EDGAR2Form NT 10-K - Notification of inability to timely file Form..
27/6/202308:00GLOBENemaura Medical Scales-Up Pilot Expansion of proBEAT™; 56..
22/6/202307:00GLOBENemaura Medical to Participate at the Collision Conference..

Su Consulta Reciente

NASDAQ
NMRD
Nemaura Medical
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados